These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
294 related articles for article (PubMed ID: 27956254)
1. BRAF-Mutated Pleomorphic Xanthoastrocytoma of the Spinal Cord with Eventual Anaplastic Transformation. Hong CS; Wang JL; Dornbos D; Joehlin-Price A; Elder JB World Neurosurg; 2017 Feb; 98():871.e9-871.e15. PubMed ID: 27956254 [TBL] [Abstract][Full Text] [Related]
2. Pleomorphic xanthoastrocytoma of the spinal cord: case report and literature review. Das S; Yip S; Hukin J; Cochrane D; Dunham C Clin Neuropathol; 2014; 33(3):190-6. PubMed ID: 24495348 [TBL] [Abstract][Full Text] [Related]
3. Role of a Promoter Mutation in TERT in Malignant Transformation of Pleomorphic Xanthoastrocytoma. Hosono J; Nitta M; Masui K; Maruyama T; Komori T; Yokoo H; Saito T; Muragaki Y; Kawamata T World Neurosurg; 2019 Jun; 126():624-630. PubMed ID: 30599247 [TBL] [Abstract][Full Text] [Related]
4. Dabrafenib in BRAFV600-mutated anaplastic pleomorphic xanthoastrocytoma. Brown NF; Carter T; Mulholland P CNS Oncol; 2017 Jan; 6(1):5-9. PubMed ID: 27781490 [TBL] [Abstract][Full Text] [Related]
5. Spinal cord anaplastic astrocytoma with BRAF V600E mutation: A case report and review of literature. Takamiya S; Hatanaka KC; Ishi Y; Seki T; Yamaguchi S Neuropathology; 2020 Jun; 40(3):275-279. PubMed ID: 31986557 [TBL] [Abstract][Full Text] [Related]
6. Clinical, Morphological, and Molecular Study on Grade 2 and 3 Pleomorphic Xanthoastrocytoma. Zhang H; Ma XJ; Xiang XP; Wang QY; Tang JL; Yu XY; Xu JH Curr Oncol; 2023 Feb; 30(2):2405-2416. PubMed ID: 36826144 [TBL] [Abstract][Full Text] [Related]
9. The genetic landscape of anaplastic pleomorphic xanthoastrocytoma. Phillips JJ; Gong H; Chen K; Joseph NM; van Ziffle J; Bastian BC; Grenert JP; Kline CN; Mueller S; Banerjee A; Nicolaides T; Gupta N; Berger MS; Lee HS; Pekmezci M; Tihan T; Bollen AW; Perry A; Shieh JTC; Solomon DA Brain Pathol; 2019 Jan; 29(1):85-96. PubMed ID: 30051528 [TBL] [Abstract][Full Text] [Related]
10. BRAF V600E mutations are common in pleomorphic xanthoastrocytoma: diagnostic and therapeutic implications. Dias-Santagata D; Lam Q; Vernovsky K; Vena N; Lennerz JK; Borger DR; Batchelor TT; Ligon KL; Iafrate AJ; Ligon AH; Louis DN; Santagata S PLoS One; 2011 Mar; 6(3):e17948. PubMed ID: 21479234 [TBL] [Abstract][Full Text] [Related]
11. BRAF mutation and anaplasia may be predictive factors of progression-free survival in adult pleomorphic xanthoastrocytoma. Tabouret E; Bequet C; Denicolaï E; Barrié M; Nanni I; Metellus P; Dufour H; Chinot O; Figarella-Branger D Eur J Surg Oncol; 2015 Dec; 41(12):1685-90. PubMed ID: 26454767 [TBL] [Abstract][Full Text] [Related]
12. Recurrent copy number alterations in low-grade and anaplastic pleomorphic xanthoastrocytoma with and without BRAF V600E mutation. Vaubel RA; Caron AA; Yamada S; Decker PA; Eckel Passow JE; Rodriguez FJ; Nageswara Rao AA; Lachance D; Parney I; Jenkins R; Giannini C Brain Pathol; 2018 Mar; 28(2):172-182. PubMed ID: 28181325 [TBL] [Abstract][Full Text] [Related]
13. BRAF-mutated pleomorphic xanthoastrocytoma is associated with temporal location, reticulin fiber deposition and CD34 expression. Koelsche C; Sahm F; Wöhrer A; Jeibmann A; Schittenhelm J; Kohlhof P; Preusser M; Romeike B; Dohmen-Scheufler H; Hartmann C; Mittelbronn M; Becker A; von Deimling A; Capper D Brain Pathol; 2014 Apr; 24(3):221-9. PubMed ID: 24345274 [TBL] [Abstract][Full Text] [Related]
14. Impact of Grade on Survival in Pleomorphic Xanthoastrocytoma and Low Prevalence of BRAF V600E Mutation. Gandham EJ; Goyal-Honavar A; Beno D; Pai R; Balakrishan R; Jasper A; Gowri M; Moorthy RK; Chacko AG; Chacko G World Neurosurg; 2022 Aug; 164():e922-e928. PubMed ID: 35618235 [TBL] [Abstract][Full Text] [Related]
15. Spinal Pleomorphic Xanthoastrocytoma With a QKI-RAF1 Fusion. Daoud EV; Wachsmann M; Richardson TE; Mella D; Pan E; Schwarzbach A; Oliver D; Hatanpaa KJ J Neuropathol Exp Neurol; 2019 Jan; 78(1):10-14. PubMed ID: 30517658 [TBL] [Abstract][Full Text] [Related]
16. BRAF V600E-mutated central nervous system tumor with divergent morphological feature - Anaplastic pleomorphic xanthoastrocytoma-like and astroblastoma-like. Purkait S; Bansal S; Malgulwar PB Neuropathology; 2019 Feb; 39(1):64-67. PubMed ID: 30557911 [TBL] [Abstract][Full Text] [Related]
17. BRAF V600E, TERT, and IDH2 Mutations in Pleomorphic Xanthoastrocytoma: Observations from a Large Case-Series Study. Ma C; Feng R; Chen H; Hameed NUF; Aibaidula A; Song Y; Wu J World Neurosurg; 2018 Dec; 120():e1225-e1233. PubMed ID: 30240866 [TBL] [Abstract][Full Text] [Related]
18. Pleomorphic xanthoastrocytoma, anaplastic pleomorphic xanthoastrocytoma, and epithelioid glioblastoma: Case series with clinical characteristics, molecular features and progression relationship. Lin Z; Yang R; Zheng H; Li Z; Yi G; Wu Q; Yang C; Huang G Clin Neurol Neurosurg; 2022 Oct; 221():107379. PubMed ID: 35932588 [TBL] [Abstract][Full Text] [Related]
19. Primary Meningeal Pleomorphic Xanthoastrocytoma With Anaplastic Features: A Report of 2 Cases, One With BRAF(V600E) Mutation and Clinical Response to the BRAF Inhibitor Dabrafenib. Usubalieva A; Pierson CR; Kavran CA; Huntoon K; Kryvenko ON; Mayer TG; Zhao W; Rock J; Ammirati M; Puduvalli VK; Lehman NL J Neuropathol Exp Neurol; 2015 Oct; 74(10):960-9. PubMed ID: 26352988 [TBL] [Abstract][Full Text] [Related]
20. Cerebellar pleomorphic xanthoastrocytoma in the setting of neurofibromatosis type-I: Does it portend a different prognosis? A case report and systematic review. Mathkour M; Banerjee S; Werner C; Hanna J; Abou-Al-Shaar H; Dindial R; Scullen T; Boehm L; Tubbs RS; Ware ML Clin Neurol Neurosurg; 2021 Jan; 200():106346. PubMed ID: 33160715 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]